Interferon-γ therapy reduces blood leukocyte levels in patients with atopic dermatitis: Correlation with clinical improvement

Clinical Immunology

Volumn 92, Issue 1, 1999, Pages 49-55

  Ellis, Charles N ^a   Stevens, Seth R ^b   Blok, Barbara K ^a   Taylor, R Stanley ^a   Cooper, Kevin D ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atopic dermatitis; Interferon ; Leukocytes; Lymphocytes

Indexed keywords

RECOMBINANT GAMMA INTERFERON;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IMMUNOTHERAPY; LEUKOCYTE COUNT; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TARGET CELL;

EID: 0033017345     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4731     Document Type: Article

References (47)

1. Fiser P. M., Buckley R. H. Human IgE biosynthesis in vitro: Studies with atopic and normal blood mononuclear cells and subpopulations. J. Immunol. 123:1979;1788-1794.
2. Van Joost T., Kozel M. M. A., Tank B., Troost R., Prens E. P. Cyclosporine in atopic dermatitis. J. Am. Acad. Dermatol. 27:1992;922-928.
3. Zachary C. B., Poulter L. W., MacDonald D. M. Cell-mediated immune responses in atopic dermatitis: The relevance of antigen-presenting cells. Br. J. Dermatol. 113:1985;10-16.
4. Ramb-Lindhauer C., Feldmann A., Rotte M., Neumann C. Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin. Arch. Dermatol. Res. 283:1991;71-76.
5. Mudde G. C., Van Reijsen F. C., Bruijnzeel-Koomen C. A. F. M. IgE-positive Langerhans cells and TH2 allergen-specific T cells in atopic dermatitis. J. Invest. Dermatol. 99:1992;103S.
6. Bruynzeel-Koomen C., van Wichen D. F., Toonstra J., Barrens L., Bruynzeel P. L. B. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch. Dermatol. Res. 278:1986;199-205.
7. Valenta R., Maurer D., Steiner R., Deiberler S., Sperr W. R., Valent P., Spitzauer S., Kapiotis S., Smolen J., Stingl G. Immunoglobulin E response to human proteins in atopic patients. J. Invest. Dermatol. 107:1996;203-208.
8. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
9. Cherwinski H. M., Schumacher J. H., Brown K. D., Mosmann T. R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1987;1229-1244.
10. Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:1989;2081-2095.
11. Spiegelberg H. L., O'Connor R. D., Falkoff R. J., Beck L. Interleukin-4 induced IgE and IgG4 secretion by B cells from atopic dermatitis patients. Int. Arch. Allergy Appl. Immunol. 94:1991;181-183.
12. Hauser C., Snapper C. M., Ohara J., Paul W. E., Katz S. I. T helper cells grown with hapten-modified cultured Langerhans' cells produce interleukin 4 and stimulate IgE production by B cells. Eur. J. Immunol. 19:1989;245-251.
13. Fabian I., Kletter Y., Mor S., Geller-Bernstein C., Ben-Yaakov M., Volovitz B., Golde D. W. Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: Comparisons of IL-1, IL-3, IL-5 and GM-CSF. Br. J. Haematol. 80:1992;137-143.
14. Clutterbuck E. J., Hirst E. M., Sanderson C. J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood. 73:1989;1504-1512.
15. Grewe M., Bruijnzeel-Koomen C. A. F. M., Schöpf E., Thepen T., Langeveld-Wildschut A. G., Ruzicka T., Krutmann J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today. 19:1998;359-361.
16. Maggi E., Biswas P., Del Prete G., Parronchi P., Macchia D., Simonelli C., Emmi L., De Carli M., Tiri A., Ricci M., Romagnani S. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 146:1991;1169-1174.
17. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 97:1991;389-394.
18. Jujo K., Renz H., Abe J., Gelfand E. W., Leung D. Y. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J. Allergy Clin. Immunol. 90:1992;323-331.
19. Reinhold U., Wehrmann W., Kukel S., Kreysel H. W. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin. Exp. Immunol. 79:1990;374-379.
20. Hunyadi J., Simon M. Jr. Expression of OKM5 antigen on human keratinocytes in vitro upon stimulation with gamma-interferon. Acta Derm. Venereol. (Stockh.). 66:1986;527-530.
21. Vercelli D., Jabara H. H., Lauener R. P., Geha R. S. IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J. Immunol. 144:1990;570-573.
22. Coffman R. L., Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J. Immunol. 136:1986;949-954.
23. Hanifin J. M., Schneider L. C., Leung D. Y. M., Ellis C. N., Jaffe H. S., Izu A. E., Bucalo L. R., Hirabayashi S. E., Tofte S. J., Cantu-Gonzales G., Milgrom H., Boguniewicz M., Cooper K. D. Recombinant interferon gamma therapy for atopic dermatitis. J. Am. Acad. Dermatol. 28:1993;189-197.
24. Stevens S. R., Shibaki A., Meunier L., Cooper K. D. Suppressor T cell-activating macrophages in UV-irradiated human skin induce a novel form of T cell activation characterized by reduced early activation gene IL-2R alpha expression. J. Immunol. 155:1995;5601-5607.
25. Schneider L. C., Baz Z., Zarcone C., Zurakowski D. Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis. Ann. Allergy Asthma. Immunol. 80:1998;263-268.
26. Stevens S. R., Hanifin J. M., Hamilton T., Tofte S. J., Cooper K. D. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch. Dermatol. 134:1998;799-804.
27. Raefsky E. L., Platanias L. C., Zoumbos N. C., Young N. S. Studies of interferon as a regulator of hematopoietic cell proliferation. J. Immunol. 135:1985;2507-2512.
28. Takahashi M., Oshimi K., Mizoguchi H. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha. Exp. Hematol. 18:1990;395-399.
29. Coutinho L. H., Testa N. G., Dexter T. M. The myelosuppressive effect of recombinant interferon gamma in short-term and long-term marrow cultures. Br. J. Haematol. 63:1986;517-524.
30. Griffiths C. E., Voorhees J. J., Nickoloff B. J. Gamma interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-I (ICAM-I) antigens. Br. J. Dermatol. 120:1989;1-8.
31. Chin Y.-H., Cai J. P., Johnson K. Lymphocyte adhesion to cultured Peyer's patch high endothelial venule cells is mediated by organ-specific homing receptors and can be regulated by cytokines. J. Immunol. 145:1990;3669-3677.
32. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis - Eosinophil granule proteins as markers of disease activity. Allergy. 48:1993;1-5.
33. Caproni, M., D'Agata, A., Cappelli, G., and Fabbri, P., Modulation of serum eosinophil cationic protein levels by cyclosporin in severe atopic dermatitis. Br. J. Dermatol.135, 336-337,[Letter].
34. Thestrup-Pedersen K., Lasen C. S., Kristensen M., Zachariae C. Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis. Acta Derm. Venereol. (Stockh.). 70:1990;395-399.
35. Kapp A. Elevated levels of soluble CD8 antigen in sera of patients with psoriasis - A possible sign of suppressor/cytotoxic T-cell activation. Arch. Dermatol. Res. 282:1990;6-7.
36. Juhlin L., Johansson G. O., Bennich H., Hogman C., Thyresson N. Immunoglobulin E in dermatoses. Levels in atopic dermatitis and urticaria. Arch. Dermatol. 100:1969;12-16.
37. Romagnani S., Del Prete G., Maggi E., Parronchi P., Tiri A., Macchia D., Giudizi M. G., Almerigogna F., Ricci M. Role of interleukins in induction and regulation of human IgE synthesis. Clin. Immunol. Immunopathol. 50:1989;S13-S23.
38. Wierenga E. A., Snoek M., De Groot C., Chretien I., Bos J. D., Jansen H. M., Kapsenberg M. L. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J. Immunol. 144:1990;4651-4656.
39. Grewe M., Gyufko K., Schopf E., Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet. 343:1994;25-26.
40. Simon M. R., Cooper K. D., Norris R. B., Blok B., King C. L. Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis: Increased interferon-γ production and lack of effects of in vivo low-dose interferon-γ treatment. J. Allergy Clin. Immunol. 96:1995;84-91.
41. Sakamoto T., Nakayama F., Tamamori T., Takigawa M. Fc epsilon receptor II/CD23+ lymphocytes in atopic dermatitis. III. Aberrant control in the in vitro expression of Fc epsilon RII/CD23 on peripheral blood T cells in atopic dermatitis. Clin. Exp. Immunol. 87:1992;87-93.
42. Prinz J. C., Baur X., Mazur G., Rieber E. P. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma. Eur. J. Immunol. 20:1990;1259-1264.
43. Muller W., Kuhn R., Rajewsky K. Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia. Eur J. Immunol. 21:1991;921-925.
44. Rousset F., Malefijt R. W., Slierendregt B., Aubry J. P., Bonnefoy J. Y., Defrance T., Banchereau J., De Vries J. E. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. J. Immunol. 140:1988;2625-2632.
45. Delespesse G., Sarfati M., Peleman R. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23). J. Immunol. 142:1989;134-138.
46. Maurer D., Stingl G. Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood. J. Invest. Dermatol. 104:1995;707-710.
47. Maurer D., Fiebiger E., Ebner C., Reininger B., Fischer G. F., Wichlas S., Jouvin M.-H., Schmitt-Egenolf M., Kraft D., Kinet J.-P., Stingl G. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα- and FcεRI-gamma-chains and can use this receptor for IgE-mediated allergen presentation. J. Immunol. 157:1996;607-616.